World’s First Clinical Trial Of Genetically-enhanced Stem Cell PAH Therapy … – Lung Disease News
Lung Disease News |
World's First Clinical Trial Of Genetically-enhanced Stem Cell PAH Therapy …
Lung Disease News A team of Canadian researchers have published promising results of the first clinical trial in the world of a genetically enhanced stem cell therapy for pulmonary arterial hypertension (PAH). This rare and deadly disease mainly affects young women, and … |
